<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Eleven biopsies from 9 patients with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were tested for their sensitivity to the cell multiplication inhibitory activity of interferon </plain></SENT>
<SENT sid="1" pm="."><plain>Three were resistant to interferon while 8 were sensitive to various degrees </plain></SENT>
<SENT sid="2" pm="."><plain>Different biopsies from the same patient did not differ in interferon sensitivity </plain></SENT>
<SENT sid="3" pm="."><plain>These results indicate that Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells might be resistant to interferon already in vivo as previously shown for some derived cell lines tested in vitro </plain></SENT>
<SENT sid="4" pm="."><plain>The results imply an inverse relationship between patient survival and interferon sensitivity of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
</text></document>